Mesirow Financial Investment Management - Fixed Income’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $13.3M | Sell |
|
|||||
|
2021
Q3 | $12.1M | Buy |
|
|||||
|
2021
Q2 | $2.39M | Buy |
|
|||||
|
2021
Q1 | $2.13M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $8.5M | Buy |
|
|||||
|
2018
Q3 | $12.7M | Sell |
|
|||||
|
2018
Q2 | $16M | Sell |
|
|||||
|
2018
Q1 | $14M | Sell |
|
|||||
|
2017
Q4 | $14.6M | Sell |
|
|||||
|
2017
Q3 | $19.3M | Sell |
|
|||||
|
2017
Q2 | $21M | Sell |
|
|||||
|
2017
Q1 | $18.5M | Sell |
|
|||||
|
2016
Q4 | $18.1M | Sell |
|
|||||
|
2016
Q3 | $21.2M | Buy |
|
|||||
|
2016
Q2 | $20.9M | Buy |
|